PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Mar-2023 Global Exosomes Market Report 2023: Sector to Reach $1.03 Billion by 2030 at a CAGR 37.75% - ResearchAndMarkets.com Businesswire
06-Mar-2023 EyeBio Announces First Asset in Innovative Pipeline of Retinal Disease Treatments and Appoints Industry Leaders to Executive Team Businesswire
06-Mar-2023 Medical Device Regulatory Affairs Global Market Report 2022: Increasing Trend Toward Portable and Smaller Devices Presents Opportunities - ResearchAndMarkets.com Businesswire
06-Mar-2023 Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8010, an Antibody Drug Conjugate Targeting HER2 for the Treatment of Advanced Solid Tumors Businesswire
06-Mar-2023 IQM Quantum Computers to Deliver Quantum Processing Units for the First Spanish Quantum Computer Businesswire
06-Mar-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Mar-2023 Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants BellaSeno GmbH
06-Mar-2023 Advicenne Announces the Launch of Sibnayal® in Denmark Businesswire
05-Mar-2023 NOTICE: Investors in Catalent, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – CTLT Businesswire
04-Mar-2023 Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial Businesswire
04-Mar-2023 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
04-Mar-2023 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
03-Mar-2023 HealthTrust Leaders to Speak at the 2023 FAH Conference and Business Exposition Businesswire
03-Mar-2023 Immune-Onc Therapeutics to Showcase Leadership in Myeloid Biology and Drug Development at Upcoming Scientific and Investor Conferences Businesswire
03-Mar-2023 Chromatography Resins Global Market Report 2022: Sector to Reach $3.1 Billion by 2027 at a CAGR of 6.71% - ResearchAndMarkets.com Businesswire
03-Mar-2023 Excalibur Investment Banking Advises Salas O’Brien on its Partnership with Plus Group Businesswire
03-Mar-2023 NanoVibronix Regains Nasdaq Compliance Businesswire
03-Mar-2023 Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of Suspected Hypertrophic Cardiomyopathy (HCM) Businesswire
03-Mar-2023 Affini-T Therapeutics to Present Data from Lead Oncogenic Driver Candidate at AACR Special Conference: Targeting RAS Businesswire
03-Mar-2023 Bristol Myers Squibb Receives European Commission Approval of Reblozyl® (luspatercept) for Anemia in Adult Patients with Non-Transfusion-Dependent Beta Thalassemia Businesswire